Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
The company said that it remains committed to maintaining full compliance with current Good Manufacturing Practice (cGMP) requirements across all its manufacturing facilities.
Supriya Lifesciences is primarily engaged in manufacturing of bulk drugs and pharmaceutical chemicals.The company’s primary focus is to build intermediaries and API for innovators and generic firms. It also exclusively collaborates with partners in the capacity of CMOs.
The company’s standalone net profit increased 6.18% to Rs 49.67 crore on 11.2% jump in revenue from operations to Rs 206.44 crore in Q4 FY26 over Q3 FY25.
The inspection concluded with the issuance of a Form 483 containing one (1) minor observation. The Company has adequately addressed the observation and has received the Establishment Inspection Report (EIR) indicating “Voluntary Action Indicated (VAI)”, signifying a successful completion of the inspection.